{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:02:58Z","timestamp":1790114578994,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007443.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"reference-count":81,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007443.pub3","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T01:44:44Z","timestamp":1583286284000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Probiotics for maintenance of remission in ulcerative colitis"],"prefix":"10.1002","author":[{"given":"Zipporah","family":"Iheozor-Ejiofor","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhbir","family":"Kaur","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"},{"name":"Families Division; Blackpool Victoria Hospital; Blackpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Anne","family":"Baines","sequence":"additional","affiliation":[{"name":"Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Sinopoulou","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Sidra Medicine; Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"10.1002\/14651858.CD007443.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease","volume":"27","author":"Bjarnason","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0002|cit2","first-page":"A375","article-title":"Maintenance of remission of ulcerative colitis: prebiotics and dietary fiber","volume":"1","author":"Copaci","year":"2014","journal-title":"United European Gastroenterology Journal"},{"issue":"5","key":"10.1002\/14651858.CD007443.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD007443.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0005|cit5","first-page":"1","article-title":"Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis","volume":"ns","author":"Matsuoka","year":"2018","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0006|cit6","unstructured":"The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients (CUPIDO) clinicaltrials.gov\/ct2\/show\/NCT02361957"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD007443.pub3-BIB0007|cit7","first-page":"A44","article-title":"A one year, randomised, double-blind, placebo controlled trial of a Lactobacillus or a Bidifobacterium probiotic for maintenance of steroid-induced remission of ulcerative colitis","volume":"130","author":"Shanahan","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18203\/issn.0019-5359.IndianJMedSci20170486","article-title":"Effects of lactobacillus casei probiotic on mild to moderate ulcerative colitis: A placebo controlled study","volume":"69","author":"Vejdani","journal-title":"Indian Journal of Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.crohns.2010.11.004","article-title":"A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis","volume":"5","author":"Wildt","year":"2011","journal-title":"Journal of Crohn's and Colitis"},{"issue":"19","key":"10.1002\/14651858.CD007443.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.3748\/wjg.v21.i19.5985","article-title":"Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis","volume":"21","author":"Yasushi","year":"2015","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD007443.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"A201","DOI":"10.1016\/S0016-5085(03)81006-5","article-title":"Comparison of Lactobacillus GG and mesalazine in maintaining remission of ulcerative colitis and Crohn's disease","volume":"124","author":"Zocco","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD007443.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","article-title":"Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis","volume":"23","author":"Zocco","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ijsu.2013.08.019","article-title":"Impact of probiotic on colonic microflora in patients with colitis: A prospective double blind randomised crossover study","volume":"11","author":"Ahmed","year":"2013","journal-title":"International Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1871530319666181221150352","article-title":"Probiotics efficacy on oxidative stress values in inflammatory bowel disease: a randomized double-blinded placebo-controlled pilot study","volume":"19","author":"Ballini","year":"2019","journal-title":"Endocrine, Metabolic & Immune Disorders - Drug Targets"},{"issue":"8","key":"10.1002\/14651858.CD007443.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1440-1746.2002.02709.x","article-title":"A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis","volume":"17","author":"Bamba","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.v10.i10.1521","article-title":"Effects of probiotics on intestinal mucosa of patients with ulcerative colitis","volume":"10","author":"Cui","year":"2004","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1345\/aph.1M498","article-title":"Probiotics for maintaining remission of ulcerative colitis in adults","volume":"44","author":"Do","year":"2010","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0016-5085(00)70272-1","article-title":"Probiotic therapy with E. Coli for ulcerative colitis: take the good with the bad","volume":"118","author":"Faubion","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub3-BIB0019|cit19","first-page":"547","article-title":"Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment","volume":"38","author":"Folwaczny","year":"2000","journal-title":"Zeitschfrift de Gastroenterologie"},{"issue":"5","key":"10.1002\/14651858.CD007443.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.nut.2008.11.017","article-title":"Randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis","volume":"25","author":"Fujimori","year":"2009","journal-title":"Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD007443.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-2008-1027463","article-title":"Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study","volume":"46","author":"Henker","year":"2008","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0022|cit22","unstructured":"Evaluation of the effects of Saccharomyces Boulardii on pain and quality of life in children with Inflammatory Bowel Disease (IBD) www.irct.ir\/trial\/32179"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/07315724.2003.10719276","article-title":"Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis","volume":"22","author":"Ishikawa","year":"2002","journal-title":"Journal of the American College of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000322977","article-title":"Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: A randomized controlled study","volume":"84","author":"Ishikawa","year":"2011","journal-title":"Digestion"},{"issue":"4","key":"10.1002\/14651858.CD007443.pub3-BIB0025|cit25","first-page":"336","article-title":"Efficacy of probiotics on ulcerative colitis and its mechanism","volume":"16","author":"Li","year":"2013","journal-title":"Zhonghua Weichang Waike Zazhi"},{"issue":"22","key":"10.1002\/14651858.CD007443.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.11569\/wcjd.v22.i22.3344","article-title":"Clinical efficacy of Salofalk combined with beneficial bacteria in patients with ulcerative colitis","volume":"22","author":"Liu","year":"2014","journal-title":"World Chinese Journal of Digestology"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ajg.2008.118","article-title":"Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis","volume":"104","author":"Miele","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0028|cit28","unstructured":"Lactobacilus acidophilus and Bifidobaceterium animalis subsp. Lactis maintenance treatment in ulcerative colitis clinicaltrials.gov\/show\/NCT00268164"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0029|cit29","unstructured":"Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus clinicaltrials.gov\/show\/NCT00374725"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0030|cit30","unstructured":"Sunbiotic treatment of ulcerative colitis patients clinialtrials.gov\/show\/NCT00803829"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0031|cit31","unstructured":"Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis clinicaltrials.gov\/show\/NCT00951548"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0032|cit32","unstructured":"Treatment of ulcerative colitis with ciprofloxacin and E. Coli Nissle clinicaltrials\/gov\/show\/NCT01772615"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5507\/bp.2016.044","article-title":"The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study","volume":"160","author":"Palumbo","year":"2016","journal-title":"Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub3-BIB0034|cit34","first-page":"556","article-title":"Comparison of mutaflor and mesalazine in the maintenance treatment of inactive ulcerative colitis","volume":"78","author":"Pelech","year":"1998","journal-title":"Prakticky Lekar"},{"issue":"9179","key":"10.1002\/14651858.CD007443.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1136\/bmjgast-2014-000018","article-title":"VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial","volume":"2","author":"Rohatgi","year":"2015","journal-title":"BMJ Open Gastroenteroilogy"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub3-BIB0037|cit37","first-page":"9","article-title":"Efectividad de probioticos sobre sintomas, histologia, y tolerancia alimentaria en colitis ulcerativa","volume":"57","author":"Sanchez-Morales","year":"2019","journal-title":"Revista Medica del Instituto Mexicano del Seguro Social"},{"issue":"4","key":"10.1002\/14651858.CD007443.pub3-BIB0038|cit38","first-page":"929","article-title":"Probiotic yogurt affects pro- and anti-inflammatory factors in patients with inflammatory bowel disease","volume":"12","author":"Shadnoush","year":"2013","journal-title":"Iranian Journal of Pharamceutical Research"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1873-9946(14)60494-3","article-title":"Probiotics can extend remission of ulcerative colitis","volume":"8","author":"Solovyeva","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL3 as adjunctive to a standard pharmaceutical treatment: A double-blind, randomized, placebo-controlled study","volume":"105","author":"Tursi","year":"2010","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD007443.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2036.1999.00560.x","article-title":"Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis","volume":"13","author":"Venturi","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.11569\/wcjd.v26.i6.373","article-title":"Effects of Bifidobacterium quadruplex live bacteria tablets on Mayo score and hs-CRP, IL-4, IL-8 in patients with mild to moderate ulcerative colitis","volume":"26","author":"Zhang","year":"2018","journal-title":"World Chinese Journal of Digestology"},{"issue":"8","key":"10.1002\/14651858.CD007443.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5152\/tjg.2019.18426","article-title":"Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease","volume":"30","author":"Fan","year":"2019","journal-title":"Turkish Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.11569\/wcjd.v26.i10.594","article-title":"Effect of mesalazine combined with bifid on inflammatory response and rectal-anal dynamics in patients with ulcerative colitis","volume":"26","author":"Fang","year":"2018","journal-title":"World Chinese Journal of Digestology"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub3-BIB0045|cit45","first-page":"2891","article-title":"Efficacy of mesalazine in combination with bifid triple viable capsules on ulcerative colitis and the resultant effect on the inflammatory factors","volume":"31","author":"Huang","year":"2018","journal-title":"Pakistan Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1002\/14651858.CD007443.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.11569\/wcjd.v26.i12.748","article-title":"Bacillus subtilis and Enterococcus faecium enteric-coated capsules combined with mesalazine for treatment of patients with ulcerative colitis: Efficacy and impact on serum levels of SOD, MDA, interleukins, and TNF-\u03b1","volume":"26","author":"Shi","year":"2018","journal-title":"World Chinese Journal of Digestology"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Yilmaz","year":"2019","journal-title":"Turkish Journal of Gastroenterology"},{"issue":"22","key":"10.1002\/14651858.CD007443.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.11569\/wcjd.v26.i22.1348","article-title":"Effects of adjuvant therapy with bifidobacterium quadruplex on lipid peroxidation injury indices, inflammatory factors and immune function in patients with ulcerative colitis","volume":"26","author":"Zhang","year":"2018","journal-title":"World Chinese Journal of Digestology"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0049|cit49","unstructured":"PRObiotic VSL#3\u00ae for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis (PROREM UC) clinicaltrials.gov\/ct2\/show\/NCT03415711"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0050|cit50","unstructured":"Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO) (PROCTO) clinicaltrials.gov\/ct2\/show\/NCT03565939"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0051|cit51","unstructured":"Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis (COLUS) clinicaltrials.gov\/ct2\/show\/NCT03798210"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0052|cit52","unstructured":"Liang J Multistrain Probiotics Reduces UC Depression and Anxiety Scores clinicaltrials.gov\/ct2\/show\/NCT04006977"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","article-title":"Variation between observers in describing mucosal appearances in proctocolitis","volume":"1","author":"Baron","year":"1964","journal-title":"British medical journal"},{"issue":"10014","key":"10.1002\/14651858.CD007443.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD007443.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2036.2010.04234.x","article-title":"Systematic review: the costs of ulcerative colitis in Western countries","volume":"31","author":"Cohen","year":"2010","journal-title":"Alimentary Pharmaology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.52.3.370","article-title":"Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment","volume":"52","author":"Dieleman","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/00365529309096063","article-title":"The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic-induced colitis in the rat","volume":"28","author":"Fabia","year":"1993","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD007443.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1756283X16647935","article-title":"The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes","volume":"9","author":"Fiorino","year":"2016","journal-title":"Therapeutic Advances in Gastroenerology"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0059|cit59","unstructured":"McMaster University GRADEpro GDT: GRADEpro Guideline Development Tool"},{"issue":"7414","key":"10.1002\/14651858.CD007443.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0061|cit61","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD007443.pub3-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011572.pub2","article-title":"Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis","author":"Jairath","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007443.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/003655200453601","article-title":"Probiotic therapy fails to improve gut permeability in a hapten model of colitis","volume":"35","author":"Kennedy","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD007443.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0016-5085(99)70013-2","article-title":"Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice","volume":"116","author":"Madsen","year":"1999","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.2001.27224","article-title":"Probiotic bacteria enhance murine and human intestinal epithelial barrier function","volume":"121","author":"Madsen","year":"2001","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub3-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005573.pub2","article-title":"Probiotics for induction of remission in ulcerative colitis","author":"Mallon","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0068|cit68","unstructured":"National Institute for Health and Care Excellence Ulcerative Colitis Mangagement NG130 https:\/\/www.nice.org.uk\/guidance\/ng130 2019"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012473.pub2","article-title":"Probiotics to prevent infantile colic","author":"Ong","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pathophys.2013.11.016","article-title":"Probiotics and prebiotics in neonatal necrotizing enterocolitis: new opportunities for translational research","volume":"21","author":"Panigrahi","year":"2014","journal-title":"Pathophysiology"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jama.281.12.1110","article-title":"Accuracy of data in abstracts of published research articles","volume":"281","author":"Pitkin","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0072|cit72","unstructured":"The Cochrane Collaboration The Nordic Centre"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00054725-200203000-00001","article-title":"Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice","volume":"8","author":"Schultz","year":"2002","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0074|cit74","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00054725-200211000-00004","article-title":"Variable response to probiotics in two models of experimental colitis in rats","volume":"8","author":"Shibolet","year":"2002","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD007443.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","article-title":"Biopsy studies in ulcerative colitis","volume":"1","author":"Truelove","year":"1956","journal-title":"British medical journal"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/mpg.0000000000002035","article-title":"Management of paediatric ulcerative colitis, Part 1: ambulatory care-an evidence-based guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"10080","key":"10.1002\/14651858.CD007443.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD007443.pub3-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000544.pub4","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","author":"Wang","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007443.pub3-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007443","article-title":"Probiotics for maintenance of remission in ulcerative colitis","author":"Fagbemi","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007443.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007443.pub2","article-title":"Probiotics for maintenance of remission in ulcerative colitis","author":"Naidoo","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:10:22Z","timestamp":1628547022000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007443.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007443.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]}}}